A. Badley, A. Sainski, F. Wightman, and S. Lewin, Altering cell death pathways as an approach to cure HIV infection, Cell Death and Disease, vol.9, issue.7, p.718, 2013.
DOI : 10.1074/jbc.M110.195537

A. Lafeuillade, Eliminating the HIV Reservoir, Current HIV/AIDS Reports, vol.6, issue.2, pp.121-131, 2012.
DOI : 10.1007/s11904-012-0115-y

A. Remoli, G. Marsili, A. Battistini, and M. Sgarbanti, The development of immune-modulating compounds to disrupt HIV latency, Cytokine & Growth Factor Reviews, vol.23, issue.4-5, pp.159-172, 2012.
DOI : 10.1016/j.cytogfr.2012.05.003

A. Monforte, V. Svicher, S. Nozza, A. Lazzarin, G. Marchetti et al., Highlights on HIV eradication in 2013, AIDS, vol.28, issue.1, 2013.
DOI : 10.1097/01.aids.0000433241.78739.79

A. Savarino and E. Garaci, Therapeutic imprinting of the immune system: towards a remission of AIDS in primates?, Retrovirology, vol.9, issue.1, p.75, 2012.
DOI : 10.1371/journal.pcbi.1000533

S. Palmer, L. Josefsson, and J. Coffin, HIV reservoirs and the possibility of a cure for HIV infection, Journal of Internal Medicine, vol.26, issue.Suppl 1, pp.550-560, 2011.
DOI : 10.1111/j.1365-2796.2011.02457.x

M. Lewis, S. Dafonseca, N. Chomont, A. Palamara, M. Tardugno et al., Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension, AIDS, vol.25, issue.11, pp.1347-1356, 2011.
DOI : 10.1097/QAD.0b013e328347bd77

N. Chomont, M. El-far, P. Ancuta, L. Trautmann, F. Procopio et al., HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation, Nature Medicine, vol.45, issue.8, pp.893-900, 2009.
DOI : 10.1038/nm.1972

N. Chomont, S. Dafonseca, C. Vandergeeten, P. Ancuta, and R. Sékaly, Maintenance of CD4+ T-cell memory and HIV persistence: keeping memory, keeping HIV, Current Opinion in HIV and AIDS, vol.6, issue.1, pp.30-36, 2011.
DOI : 10.1097/COH.0b013e3283413775

D. Finzi, J. Blankson, J. Siliciano, J. Margolick, K. Chadwick et al., Latent infection of CD4 þ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy, Nat Med, vol.5, pp.512-517, 1999.

I. Shytaj, S. Norelli, B. Chirullo, D. Corte, A. Collins et al., A Highly Intensified ART Regimen Induces Long-Term Viral Suppression and Restriction of the Viral Reservoir in a Simian AIDS Model, PLoS Pathogens, vol.3, issue.16, p.1002774, 2012.
DOI : 10.1371/journal.ppat.1002774.s016

I. Shytaj, B. Chirullo, W. Wagner, M. Ferrari, R. Sgarbanti et al., Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS, Retrovirology, vol.10, issue.1, p.71, 2013.
DOI : 10.1126/scitranslmed.3001628

R. Eisler, Chrysotherapy: a synoptic review, Inflammation Research, vol.52, issue.12, pp.487-501, 2003.
DOI : 10.1007/s00011-003-1208-2

S. Friker, Medical uses of gold compounds: past, present and future, Gold Bull, vol.29, pp.53-59, 1996.

B. Sutton, Gold compounds for rheumatoid arthritis, Gold Bulletin, vol.224, issue.1, pp.15-16, 1986.
DOI : 10.1007/BF03214639

W. Kean, L. Hart, W. Buchanan, and . Auranofin, Auranofin, Rheumatology, vol.36, issue.5, pp.560-572, 1997.
DOI : 10.1093/rheumatology/36.5.560

K. Hashimoto, C. Whitehurst, and P. Lipsky, Synergistic inhibition of T cell proliferation by gold sodium thiomalate and auranofin, J Rheumatol, vol.21, pp.1020-1026, 1994.

S. Han, K. Kim, H. Kim, J. Kwon, Y. Lee et al., Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages, Archives of Pharmacal Research, vol.15, issue.1, pp.67-74, 2008.
DOI : 10.1007/s12272-008-1122-9

T. Kim, B. Kang, M. Lee, Y. Choe, and S. Hwang, T cells from the Th1 to the Th2 pathway, British Journal of Pharmacology, vol.161, issue.3, pp.571-578, 2001.
DOI : 10.1038/sj.bjp.0704298

S. Gromer, J. Wissing, D. Behne, K. Ashman, R. Schirmer et al., A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase, Biochemical Journal, vol.332, issue.2, pp.591-592, 1998.
DOI : 10.1042/bj3320591

M. Rigobello, G. Scutari, R. Boscolo, and A. Bindoli, Induction of mitochondrial permeability transition by auranofin, a Gold(I)-phosphine derivative, British Journal of Pharmacology, vol.1241, issue.Suppl., pp.1162-1168, 2002.
DOI : 10.1038/sj.bjp.0704823

M. Rigobello, A. Folda, B. Dani, R. Menabo, G. Scutari et al., Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells, European Journal of Pharmacology, vol.582, issue.1-3, pp.26-34, 2008.
DOI : 10.1016/j.ejphar.2007.12.026

A. Cox, K. Brown, E. Arner, and M. Hampton, The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation, Biochemical Pharmacology, vol.76, issue.9, pp.1097-1109, 2008.
DOI : 10.1016/j.bcp.2008.08.021

M. López, V. Soriano, A. Peris-pertusa, N. Rallón, C. Restrepo et al., Elite Controllers Display Higher Activation on Central Memory CD8 T Cells Than HIV Patients Successfully on HAART, AIDS Research and Human Retroviruses, vol.27, issue.2, pp.157-165, 2011.
DOI : 10.1089/aid.2010.0107

M. Hazenberg, S. Otto, B. Van-benthem, M. Roos, R. Coutinho et al., Persistent immune activation in HIV-1 infection is associated with progression to AIDS, AIDS, vol.17, issue.13, pp.1881-1888, 2003.
DOI : 10.1097/00002030-200309050-00006

C. Liu, Z. Liu, M. Li, X. Li, Y. Wong et al., Enhancement of Auranofin-Induced Apoptosis in MCF-7 Human Breast Cells by Selenocystine, a Synergistic Inhibitor of Thioredoxin Reductase, PLoS ONE, vol.286, issue.1, p.53945, 2013.
DOI : 10.1371/journal.pone.0053945.g009

H. Sies, Glutathione and its role in cellular functions, Free Radical Biology and Medicine, vol.27, issue.9-10, pp.916-921, 1999.
DOI : 10.1016/S0891-5849(99)00177-X

S. Lin, D. Razo, L. Styblo, M. Wang, C. Cullen et al., Arsenicals Inhibit Thioredoxin Reductase in Cultured Rat Hepatocytes, Chemical Research in Toxicology, vol.14, issue.3, pp.305-311, 2001.
DOI : 10.1021/tx0001878

J. Mccubrey, M. Lahair, and R. Franklin, Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways, Antioxidants & Redox Signaling, vol.8, issue.9-10, pp.1775-1789, 2006.
DOI : 10.1089/ars.2006.8.1775

M. Cobb, MAP kinase pathways, Progress in Biophysics and Molecular Biology, vol.71, issue.3-4, pp.479-500, 1999.
DOI : 10.1016/S0079-6107(98)00056-X

T. Sugawara, T. Moriguchi, E. Nishida, and Y. Takahama, Differential Roles of ERK and p38 MAP Kinase Pathways in Positive and Negative Selection of T Lymphocytes, Immunity, vol.9, issue.4, pp.565-574, 1998.
DOI : 10.1016/S1074-7613(00)80639-1

J. Nordberg and E. Arnér, Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis ???Thioredoxin reductase???interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid??? by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4., Free Radical Biology and Medicine, vol.31, issue.11, pp.1287-1312, 2001.
DOI : 10.1016/S0891-5849(01)00724-9

P. Wardman, Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: Progress, pitfalls, and prospects, Free Radical Biology and Medicine, vol.43, issue.7, pp.995-1022, 2007.
DOI : 10.1016/j.freeradbiomed.2007.06.026

G. Filomeni, S. Piccirillo, G. Rotilio, and M. Ciriolo, p38MAPK and ERK1/2 dictate cell death/survival response to different pro-oxidant stimuli via p53 and Nrf2 in neuroblastoma cells SH-SY5Y, Biochemical Pharmacology, vol.83, issue.10, pp.1349-1357, 2012.
DOI : 10.1016/j.bcp.2012.02.003

H. Fenton, LXXIII.???Oxidation of tartaric acid in presence of iron, J. Chem. Soc., Trans., vol.65, issue.0, pp.899-910, 1894.
DOI : 10.1039/CT8946500899

M. Cobb and E. Goldsmith, How MAP Kinases Are Regulated, Journal of Biological Chemistry, vol.270, issue.25, pp.14843-14846, 1995.
DOI : 10.1074/jbc.270.25.14843

M. Karin, The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases, Journal of Biological Chemistry, vol.270, issue.28, pp.16483-16486, 1995.
DOI : 10.1074/jbc.270.28.16483

K. Ohno and J. Han, The p38 signal transduction pathway Activation and function, Cellular Signalling, vol.12, issue.1, pp.1-13, 2000.
DOI : 10.1016/S0898-6568(99)00071-6

G. Filomeni and M. Ciriolo, Redox Control of Apoptosis: An Update, Antioxidants & Redox Signaling, vol.8, issue.11-12, pp.2187-2192, 2006.
DOI : 10.1089/ars.2006.8.2187

K. Chang, C. Hsu, S. Liu, C. Su, C. Yen et al., Cadmium Induces Apoptosis in Pancreatic ??-Cells through a Mitochondria-Dependent Pathway: The Role of Oxidative Stress-Mediated c-Jun N-Terminal Kinase Activation, PLoS ONE, vol.69, issue.2, p.54374, 2013.
DOI : 10.1371/journal.pone.0054374.s004

W. Zhao, S. Tang, J. X. Zhang, C. Zhang, T. Wang et al., Olaquindox-induced apoptosis is suppressed through p38 MAPK and ROS-mediated JNK pathways in HepG2 cells, Cell Biology and Toxicology, vol.285, issue.4, pp.229-238, 2013.
DOI : 10.1007/s10565-013-9249-y

G. Buettner, Superoxide Dismutase in Redox Biology: The Roles of Superoxide and Hydrogen Peroxide, Anti-Cancer Agents in Medicinal Chemistry, vol.11, issue.4, pp.341-346, 2011.
DOI : 10.2174/187152011795677544

A. Takahashi, M. Hanson, H. Norell, A. Havelka, K. Kono et al., Preferential Cell Death of CD8+ Effector Memory (CCR7-CD45RA-) T Cells by Hydrogen Peroxide-Induced Oxidative Stress, The Journal of Immunology, vol.174, issue.10, pp.6080-6087, 2005.
DOI : 10.4049/jimmunol.174.10.6080

N. Farley, G. Pedraza-alva, D. Serrano-gomez, V. Nagaleekar, A. Aronshtam et al., p38 Mitogen-Activated Protein Kinase Mediates the Fas-Induced Mitochondrial Death Pathway in CD8+ T Cells, Molecular and Cellular Biology, vol.26, issue.6, pp.2118-2129, 2006.
DOI : 10.1128/MCB.26.6.2118-2129.2006

A. Weiss and D. Littman, Signal transduction by lymphocyte antigen receptors, Cell, vol.76, issue.2, pp.263-274, 1994.
DOI : 10.1016/0092-8674(94)90334-4

H. Marjuki, M. Alam, C. Ehrhardt, R. Wagner, O. Planz et al., Membrane Accumulation of Influenza A Virus Hemagglutinin Triggers Nuclear Export of the Viral Genome via Protein Kinase C??-mediated Activation of ERK Signaling, Journal of Biological Chemistry, vol.281, issue.24, pp.16707-16715, 2006.
DOI : 10.1074/jbc.M510233200

V. Espina, K. Edmiston, M. Heiby, M. Pierobon, M. Sciro et al., A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process, Molecular & Cellular Proteomics, vol.7, issue.10, pp.1998-2018, 2008.
DOI : 10.1074/mcp.M700596-MCP200